AzTrials
AzTrials

Medical StudentsNCT03653221

Developing of Virtual Reality Based Neurologic Examination Teaching Tool(VRNET)

A study testing Standard patients with VRNET and standard patients in people with Medical Students, run by Yonsei University at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effect of the virtual reality based neurologic examination teaching tool(VRNET) for medical students. VRNET is a new teaching tool for neurologic examinations by offering different neurologic signs of the face, with which medical students can experience more realistic… Read more about this study

Who is it for?
Ages 23 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Medical Students
What is being tested?
Standard patients with VRNET and standard patients
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
95 participants
Where
1 siteSouth Korea
Study dates
18 Mar 2019to 12 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 23 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 4th grade medical students of emergency medicine clerkship who agree with participation on this study.

Who cannot join

  • Disagree with participation on this study.
  • Who are absent the last day of clerkship.

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Department of emergency medicine, Yonsei University College of Medicine, Seoul, Korea

    Seoul, 03722

Other trials in South Korea

About this study

The purpose of this study is to evaluate the effect of the virtual reality based neurologic examination teaching tool(VRNET) for medical students. VRNET is a new teaching tool for neurologic examinations by offering different neurologic signs of the face, with which medical students can experience more realistic patients.

Being tested
Standard patients with VRNET, standard patients

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard patients with VRNETOther

    In group of standard patients with VRNET, the medical students examine the standard patient of neurologic deficits. When they examine, they get some information of neurologic signs via the VRNET which presents neurologic deficits directly by alternating facial expressions. The students should interpret that signs to have a diagnosis.

  • standard patientsOther

    In group of standard patients, those neurological deficits are presented only by words or pictures which are not realistic.

Study groups in NCT03653221
Study groupRoleWhat they receive
standardized patients with VRNETExperimentalThe medical students examine the standardized patients who have neurological deficits which presented by VRNET.
Receives: Other: Standard patients with VRNET
standardized patientsPlacebo comparatorThe medical students examine the standardized patients who have neurological deficits which presented by words or pictures.
Receives: Other: standard patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurologic physical exam(NPE) score

    NPE score is consist of 6 neurologic examination parts; cranial nerve, motor, sensory, cerebellar function, gait. Each part has 1 points, so NPE score ranges from 0 to 6. NPE score of students is evaluated by neurologist viewing video clips which recorded during the last day of 2 weeks clerkship rotation.

    Measured: after 2 weeks clinical clerkship rotation.

Secondary outcomes (3)
  1. Satisfaction of students for VRNET

    Satisfaction of VRNET are evaluated by students' answer to the question below with Likert scale (0 to 5) after completion examination of standard patient.

    "I am satisfied with VRNET for neurologic examination training. 0 (not at all)---1----2----3-----4-----5 (very helpful)"

    Measured: after 2 weeks clinical clerkship rotation.

  2. Reality of VRNET by students

    Reality of VRNET are evaluated by students' answer to the question below with Likert scale (0 to 5) after completion examination of standard patient.

    "VRNET is very realistic. 0 (not at all)---1----2----3-----4-----5 (very realistic)"

    Measured: after 2 weeks clinical clerkship rotation.

  3. Evaluation of students by standardized patients

    Evaluation of students by standard patients is also using Likert scale (0 to 5) based on the pre-made check lists.

    "How do you feel as a standard patient that the student did good job?" 0 (not at all)---1----2----3-----4-----5 (very competent)

    Measured: after 2 weeks clinical clerkship rotation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2018
  2. Study start18 Mar 2019
  3. Primary completion12 Jul 2019
  4. Study completion12 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Single group
Model description
1. standardized patients with VRNET 2. standardized patients
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
95 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03653221
Sponsor's protocol ID
4-2018-0665
Status last verified
Oct 2020
First submitted
27 Aug 2018
Last updated
19 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Standard patients with VRNET and standard patients in people with Medical Students, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neurologic physical exam(NPE) score (time frame: after 2 weeks clinical clerkship rotation.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in